This renowned pharmaceutical multinational decided to phase out its research facilities with 180 emloyees at its headquarters.
PIPM bought all the redundant assets, which were located in different buildings and laboratory areas. This concerned a large amount of laboratory equipment, including micronisation units, rotary dryers, rotary evaporators, chemical reaction systems, dye chambers, filters, and tempering plants.
The client wanted as little external traffic as possible on the company premises, so PIPM organised the dismantling, packaging and transport of the assets. The project was successfully completed in 4 months and 450 assets were sold worldwide.